• LAST PRICE
    33.3800
  • TODAY'S CHANGE (%)
    Trending Up0.8300 (2.5499%)
  • Bid / Lots
    22.8000/ 1
  • Ask / Lots
    33.8500/ 1
  • Open / Previous Close
    32.9500 / 32.5500
  • Day Range
    Low 32.6700
    High 33.4400
  • 52 Week Range
    Low 22.1000
    High 41.4600
  • Volume
    354,644
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 32.55
TimeVolumeCERE
09:32 ET329332.96
09:36 ET110033.1375
09:38 ET174033.42
09:39 ET442833.15
09:41 ET80032.95
09:43 ET30032.945
09:48 ET30032.93
09:52 ET40032.79
09:54 ET20032.82
09:56 ET50032.95
09:57 ET102832.81
09:59 ET10032.75
10:01 ET10032.81
10:03 ET20032.6721
10:06 ET130032.715
10:08 ET80032.76
10:10 ET410332.72
10:12 ET30032.82
10:14 ET260132.9
10:15 ET20032.74
10:17 ET10032.87
10:19 ET1277033.05
10:21 ET359033.12
10:24 ET268633.08
10:26 ET60033.13
10:28 ET30033.21
10:32 ET90033.18
10:35 ET20033.17
10:37 ET30033.16
10:39 ET130033.22
10:42 ET140033.26
10:44 ET10033.25
10:46 ET10033.23
10:48 ET30033.14
10:50 ET10033.11
10:51 ET20033.01
10:53 ET20032.985
10:55 ET10032.945
10:57 ET41032.91
11:00 ET69332.98
11:02 ET20033.06
11:04 ET10033.09
11:06 ET10033.04
11:09 ET60033.05
11:11 ET30033.09
11:13 ET110233.03
11:15 ET180033.045
11:18 ET37033.1373
11:20 ET30033.065
11:26 ET20033.0075
11:27 ET30033.03
11:31 ET20032.97
11:38 ET10033.01
11:40 ET20033
11:42 ET80033.056
11:44 ET40033.14
11:47 ET20033.08
11:49 ET10033.105
11:51 ET20033.07
11:54 ET30033.04
11:56 ET100033.02
12:00 ET10033.04
12:03 ET116632.89
12:09 ET40032.97
12:18 ET74233.01
12:20 ET10033.01
12:21 ET20033.05
12:23 ET30033
12:25 ET60033.05
12:27 ET50033.1
12:30 ET50033.15
12:34 ET20033.15
12:36 ET10033.17
12:39 ET50033.25
12:41 ET20033.295
12:43 ET50033.22
12:45 ET10033.22
12:48 ET59033.3
12:50 ET10033.265
12:52 ET10033.315
12:54 ET110533.28
12:56 ET352533.265
12:59 ET120033.25
01:01 ET90033.31
01:06 ET10033.245
01:08 ET10033.24
01:12 ET20033.33
01:15 ET19833.326
01:17 ET108833.31
01:24 ET20033.36
01:26 ET30033.27
01:30 ET30033.38
01:32 ET10033.37
01:33 ET10033.37
01:35 ET70033.4
01:37 ET20033.39
01:39 ET30033.34
01:42 ET25833.37
01:44 ET40033.27
01:46 ET30033.315
01:50 ET60033.35
01:51 ET20033.335
01:53 ET30033.358
01:57 ET20033.36
02:02 ET10033.37
02:04 ET80033.37
02:06 ET10033.39
02:08 ET71133.27
02:09 ET40033.27
02:11 ET10033.27
02:13 ET30033.28
02:15 ET10033.28
02:18 ET40033.32
02:20 ET918533.2
02:22 ET20033.23
02:26 ET10033.28
02:31 ET30033.36
02:33 ET70033.27
02:36 ET10033.32
02:40 ET131533.31
02:45 ET10033.28
02:47 ET90033.36
02:49 ET60033.33
02:51 ET30033.345
02:58 ET80033.386
03:00 ET10033.31
03:02 ET50033.37
03:03 ET10033.36
03:05 ET10033.395
03:07 ET51333.37
03:09 ET76933.36
03:12 ET70033.36
03:14 ET130033.38
03:16 ET40033.37
03:18 ET260033.38
03:20 ET208933.31
03:21 ET221833.215
03:23 ET110033.185
03:25 ET40033.14
03:27 ET143833.225
03:30 ET30033.254
03:32 ET30033.25
03:34 ET40033.31
03:36 ET124533.27
03:39 ET50033.26
03:41 ET93933.29
03:43 ET56233.32
03:45 ET71333.271
03:48 ET112333.24
03:50 ET61233.28
03:52 ET150033.28
03:54 ET94833.315
03:56 ET407933.35
03:57 ET373633.365
03:59 ET849433.38
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCERE
Cerevel Therapeutics Holdings Inc
5.2B
-13.2x
---
United StatesISEE
IVERIC bio Inc
5.2B
-21.6x
---
United StatesCRSP
CRISPR Therapeutics AG
5.1B
-9.7x
---
United StatesMDGL
Madrigal Pharmaceuticals Inc
4.8B
-14.4x
---
United StatesPCVX
Vaxcyte Inc
4.8B
-14.8x
---
United StatesASND
Ascendis Pharma A/S
5.2B
-8.4x
---
As of 2023-06-03

Company Information

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It is engaged in the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer's disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Its pipeline with various clinical trials underway or planned, including three ongoing Phase III trials and an open-label extension trial for tavapadon in Parkinson's, two planned Phase II trials and a planned open-label extension trial for emraclidine in schizophrenia and an ongoing Phase II proof-of-concept trial with an open-label extension trial for darigabat in focal epilepsy.

Contact Information

Headquarters
222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
Phone
212-284-2300
Fax
302-636-5454

Executives

Chairperson of the Board of Directors
N. Anthony Coles
Chief Financial Officer
Susan Altschuller
Chief Human Resources Officer
Kenneth Dipietro
Senior Vice President - Finance, Chief Accounting Officer
Mark Bodenrader
Chief Scientific Officer
John Renger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.2B
Revenue (TTM)
$0.00
Shares Outstanding
156.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.53
Book Value
$3.33
P/E Ratio
-13.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.